The majority of lipo-CAF-associated genes were highly expressed in gastric cancer. Patients were stratified into high- and low-risk groups based on gene expression patterns and these groups exhibited differences in prognosis, energy metabolism-associated pathways and immune infiltration. A prognostic model was constructed using these genes and externally validated. Findings indicated that fatty acid-binding protein 4 (FABP4), CD36 and ATP-binding cassette subfamily A member 8 (ABCA8) may exert tumor-promoting roles in gastric cancer. In fibroblast-based co-culture experiments, knockdown of these three genes in NIH-3T3 cells inhibited the proliferation of co-cultured gastric cancer cells. Lipo-CAF-associated genes were found to be coupled with gastric cancer progression and with distinct immune and stromal features of the tumor microenvironment. Among these genes, FABP4, CD36 and ABCA8 demonstrated tumor-promoting effects in fibroblast-based co-culture experiments, highlighting their potential relevance for prognostic stratification and future therapeutic investigation in gastric cancer.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: